Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
0.882
-0.068 (-7.15%)
At close: Apr 28, 2026, 4:00 PM EDT
0.851
-0.032 (-3.62%)
Pre-market: Apr 29, 2026, 8:31 AM EDT
Lexaria Bioscience Cash Flow Statement
Financials in millions USD. Fiscal year is September - August.
Millions USD. Fiscal year is Sep - Aug.
| TTM
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Feb '26 Feb 28, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 |
| Net Income | -9.53 | -11.9 | -5.8 | -6.66 | -7.27 | -4.03 | |
| Depreciation & Amortization | 0.12 | 0.12 | 0.11 | 0.19 | 0.14 | 0.15 | |
| Asset Writedown & Restructuring Costs | 0.21 | 0.25 | 0.06 | 0.11 | - | - | |
| Loss (Gain) From Sale of Investments | 0.07 | 0.03 | 0.07 | 0.22 | 0.76 | 0.17 | |
| Stock-Based Compensation | 0.74 | 0.86 | 0.49 | 0.17 | 1.95 | 1.28 | |
| Provision & Write-off of Bad Debts | - | - | 0.01 | - | - | 0.05 | |
| Other Operating Activities | -0 | -0 | -0.01 | -0.05 | -0.12 | -0.15 | |
| Change in Accounts Receivable | 0.29 | -0.21 | -0.04 | 0.03 | -0.14 | 0.19 | |
| Change in Inventory | - | - | - | 0.04 | -0 | 0.1 | |
| Change in Accounts Payable | -1.61 | 0.4 | 0.83 | 0.09 | 0.05 | 0.01 | |
| Change in Unearned Revenue | 0 | -0 | 0 | - | - | -0.04 | |
| Change in Other Net Operating Assets | 0.33 | 0.02 | -0.69 | -0.01 | -0.26 | -0.19 | |
| Operating Cash Flow | -9.37 | -10.45 | -4.96 | -5.88 | -4.88 | -3.99 | |
| Capital Expenditures | -0.04 | -0.02 | -0.04 | -0.03 | -0.05 | - | |
| Sale of Property, Plant & Equipment | - | - | - | - | - | 0.27 | |
| Sale (Purchase) of Intangibles | -0.05 | -0.08 | -0.15 | -0.14 | -0.13 | -0.08 | |
| Investment in Securities | -0.14 | -0.14 | - | - | - | - | |
| Investing Cash Flow | -0.24 | -0.24 | -0.19 | -0.17 | -0.18 | 0.19 | |
| Long-Term Debt Repaid | - | - | - | - | -0.04 | -0.07 | |
| Net Debt Issued (Repaid) | - | - | - | - | -0.04 | -0.07 | |
| Issuance of Common Stock | 8.21 | 6.05 | 10.32 | 1.59 | - | 13.49 | |
| Financing Cash Flow | 8.21 | 6.05 | 10.32 | 1.59 | -0.04 | 13.42 | |
| Foreign Exchange Rate Adjustments | 0.06 | -0.05 | -0.02 | - | - | - | |
| Net Cash Flow | -1.34 | -4.7 | 5.15 | -4.46 | -5.1 | 9.62 | |
| Free Cash Flow | -9.42 | -10.48 | -5 | -5.91 | -4.93 | -3.99 | |
| Free Cash Flow Margin | -2558.49% | -1483.88% | -1077.38% | -2614.84% | -1929.75% | -552.02% | |
| Free Cash Flow Per Share | -0.45 | -0.58 | -0.40 | -0.89 | -0.84 | -0.91 | |
| Cash Income Tax Paid | 0 | - | - | 0.01 | -0 | -0.02 | |
| Levered Free Cash Flow | -5.93 | -6.16 | -2.98 | -3.6 | -2.3 | -2.37 | |
| Unlevered Free Cash Flow | -5.93 | -6.16 | -2.98 | -3.6 | -2.3 | -2.37 | |
| Change in Working Capital | -0.99 | 0.2 | 0.11 | 0.14 | -0.35 | 0.06 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.